Formulary Apportionment for the Internal Market

The study is comprised of four parts. First, a theoretical concept of formulary apportionment is presented in order to define the role that formulary apportionment could take in the area of profit allocation within the Internal Market.

Why this book?

The study is comprised of four parts. First, a theoretical concept of formulary apportionment is presented in order to define the role that formulary apportionment could take in the area of profit allocation within the Internal Market. This is followed by an in-depth evaluation of the practical experiences of four jurisdictions (United States, Canada, Switzerland and Germany) with formulary apportionment at the subnational level. Next, a comprehensive proposal for harmonization on the basis of consolidation and apportionment is developed, using the insights from the foregoing theoretical considerations and comparative analysis.

The book concludes with an overall analysis of the merits and drawbacks of the proposed model for harmonization which suggests that consolidation and formulary apportionment could indeed represent a workable solution to numerous problems of corporate taxation within the Internal Market.

Downloads

Sample excerpt, including table of contents

This book is part of the IBFD Doctoral Series

View other titles in the series

Author(s)

Stefan Mayer studied law and qualified as a lawyer in Munich. He received an LL.M. in Taxation from the London School of Economics and Political Science, and has worked as an academic assistant and scholarship holder at the Max Planck Institute for Intellectual Property, Competition and Tax Law (Munich). Currently, Mr Mayer works with the tax department of Latham & Watkins LLP in Munich.